Medirom Net Income From Continuing Ops from 2010 to 2026
| MRM Stock | USD 1.33 0.01 0.76% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 158.9 M | Current Value 166.9 M | Quarterly Volatility 376.1 M |
Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom Healthcare's main balance sheet or income statement drivers, such as Interest Income of 8.7 K, Depreciation And Amortization of 350.2 M or Interest Expense of 60.1 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.84. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.
Medirom | Net Income From Continuing Ops | Build AI portfolio with Medirom Stock |
Evaluating Medirom Healthcare's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Medirom Healthcare Technologies's fundamental strength.
Latest Medirom Healthcare's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Medirom Healthcare Technologies over the last few years. It is Medirom Healthcare's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medirom Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Medirom Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (42,839,219) | |
| Geometric Mean | 106,433,986 | |
| Coefficient Of Variation | (877.99) | |
| Mean Deviation | 233,494,537 | |
| Median | 66,310,000 | |
| Standard Deviation | 376,122,707 | |
| Sample Variance | 141468.3T | |
| Range | 1.2B | |
| R-Value | (0.10) | |
| Mean Square Error | 149375.8T | |
| R-Squared | 0.01 | |
| Significance | 0.70 | |
| Slope | (7,484,574) | |
| Total Sum of Squares | 2263492.7T |
Medirom Net Income From Continuing Ops History
About Medirom Healthcare Financial Statements
Medirom Healthcare investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Medirom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 158.9 M | 166.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Medirom Healthcare Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Health Care Providers & Services sector continue expanding? Could Medirom diversify its offerings? Factors like these will boost the valuation of Medirom Healthcare. Expected growth trajectory for Medirom significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Medirom Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.278 | Earnings Share 0.39 | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
Understanding Medirom Healthcare requires distinguishing between market price and book value, where the latter reflects Medirom's accounting equity. The concept of intrinsic value - what Medirom Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Medirom Healthcare's price substantially above or below its fundamental value.
Understanding that Medirom Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medirom Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medirom Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.